Christian G. Giske

Om mig
Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Om mig

Professor i klinisk bakteriologi vid institutionen för laboratoriemedicin

Christian Giske är född 1975 i Ålesund, Norge. Han fick sin läkarutbildning vid Norges teknisk-naturvitenskapelige universitet, Trondheim, med examen 2000. 2002 gjorde han militärtjänst som officer och läkare i norska flottan. Sedan 2002 arbetar han på Karolinska Universitetslaboratoriet, Karolinska Universitetssjukhuset, där han idag är överläkare.

Giske blev specialist i klinisk mikrobiologi 2007 och disputerade vid KI samma år med en avhandling om antibiotikaresistens hos bakterien Pseudomonas aeruginosa. Han blev docent 2010. Christian Giske har anställts som professor i klinisk bakteriologi vid Karolinska Institutet från 1 juni 2018.

Utvalda publikationer

Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2024;64(3):107256
Resistance to aztreonam-avibactam among clinical isolates of Escherichia coli is primarily mediated by altered penicillin-binding protein 3 and impermeability
Tellapragada C; Razavi M; Peris PS; Jonsson P; Vondracek M; Giske CG
Article: THE LANCET MICROBE. 2024;5(4):e355-e365
Effect of tebipenem pivoxil hydrobromide on the normal gut microbiota of a healthy adult population in Sweden: a randomised controlled trial
Sewunet T; Razavi M; Rosenborg S; Camporeale A; Nowak M; Melnick D; Gasink LB; Eckburg PB; Critchley IA; Nord CE; Giske CG
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2024;79(3):531-538
Treatment, outcomes and characterization of pathogens in urinary tract infections caused by ESBL-producing Enterobacterales: a prospective multicentre study
Montelin H; Camporeale A; Hallgren A; Angelin M; Hogvall J; Balkhed AO; Vading M; Giske CG; Tangden T
Article: MICROBIOLOGY SPECTRUM. 2024;12(2):e0403622-e04022
Molecular characteristics, fitness, and virulence of high-risk and non-high-risk clones of carbapenemase-producing Klebsiella pneumoniae
Ormala-Tiznado A-M; Allander L; Maatallah M; Kabir MH; Brisse S; Sandegren L; Patpatia S; Coorens M; Giske CG
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2023;78(12):2895-2901
Swedish multicentre study of target attainments with β-lactams in the ICU: which MIC parameter should be used?
Smekal A-K; Furebring M; Lipcsey M; Giske CG
Article: CLINICAL INFECTIOUS DISEASES. 2023;76(3):469-478
Association Between Time to Appropriate Antimicrobial Treatment and 30-day Mortality in Patients With Bloodstream Infections: A Retrospective Cohort Study
Van Heuverswyn J; Valik JK; van der Werff SD; Hedberg P; Giske C; Naucler P
Article: INFECTIOUS DISEASES AND THERAPY. 2022;11(4):1505-1519
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study
Babich T; Naucler P; Valik JK; Giske CG; Benito N; Cardona R; Rivera A; Pulcini C; Fattah MA; Haquin J; Macgowan A; Grier S; Chazan B; Yanovskay A; Ben Ami R; Landes M; Nesher L; Zaidman-Shimshovitz A; McCarthy K; Paterson DL; Tacconelli E; Buhl M; Mauer S; Rodriguez-Bano J; de Cueto M; Oliver A; de Gopegui ER; Cano A; Machuca I; Gozalo-Marguello M; Martinez-Martinez L; Gonzalez-Barbera EM; Alfaro IG; Salavert M; Beovic B; Saje A; Mueller-Premru M; Pagani L; Vitrat V; Kofteridis D; Zacharioudaki M; Maraki S; Weissman Y; Paul M; Dickstein Y; Leibovici L; Yahav D
Article: THE LANCET INFECTIOUS DISEASES. 2022;22(3):390-400
The clinical and microbiological efficacy of temocillin versus cefotaxime in adults with febrile urinary tract infection, and its effects on the intestinal microbiota: a randomised multicentre clinical trial in Sweden
Edlund C; Ternhag A; Stahlgren GS; Edquist P; Balkhed AO; Athlin S; Mansson E; Tempe M; Bergstrom J; Giske CG; Hanberger H
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021;76(8):2172-2181
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study
Babich T; Naucler P; Valik JK; Giske CG; Benito N; Cardona R; Rivera A; Pulcini C; Fattah MA; Haquin J; MacGowan A; Grier S; Gibbs J; Chazan B; Yanovskay A; Ben Ami R; Landes M; Nesher L; Zaidman-Shimshovitz A; McCarthy K; Paterson DL; Tacconelli E; Buhl M; Mauer S; Rodriguez-Bano J; Morales I; Oliver A; Ruiz de Gopegui E; Cano A; Machuca I; Gozalo-Marguello M; Martinez Martinez L; Gonzalez-Barbera EM; Gomez Alfaro I; Salavert M; Beovic B; Saje A; Mueller-Premru M; Pagani L; Vitrat V; Kofteridis D; Zacharioudaki M; Maraki S; Weissman Y; Paul M; Dickstein Y; Leibovici L; Yahav D
Article: JAC-ANTIMICROBIAL RESISTANCE. 2021;3(1):dlab001
High prevalence of bla_CTX-M-15 and nosocomial transmission of hypervirulent epidemic clones of Klebsiella pneumoniae at a tertiary hospital in Ethiopia
Sewunet T; Asrat D; Woldeamanuel Y; Ny S; Westerlund F; Aseffa A; Giske CG

Artiklar

Journal article: THE LANCET MICROBE. 2024;5(11):100902
WHO global research priorities for antimicrobial resistance in human health.
Bertagnolio S; Dobreva Z; Centner CM; Olaru ID; Donà D; Burzo S; Huttner BD; Chaillon A; Gebreselassie N; Wi T; Hasso-Agopsowicz M; Allegranzi B; Sati H; Ivanovska V; Kothari KU; Balkhy HH; Cassini A; Hamers RL; Weezenbeek KV; WHO Research Agenda for AMR in Human Health Collab
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2024;43(5):959-968
A decade of neonatal sepsis in Stockholm, Sweden: Gram-positive pathogens were four times as common as Gram-negatives
Oldendorff F; Nordberg V; Giske CG; Naver L
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2024;30(4):469-480
Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group
Oliver A; Rojo-Molinero E; Arca-Suarez J; Besli Y; Bogaerts P; Canton R; Cimen C; Croughs PD; Denis O; Giske CG; Graells T; Huang T-DD; Iorga BI; Karatuna O; Kocsis B; Kronenberg A; Lopez-Causape C; Malhotra-Kumar S; Martinez LM; Mazzariol A; Meyer S; Naas T; Notermans DW; Oteo-Iglesias J; Pedersen T; Pirs M; Poeta P; Poirel L; Pournaras S; Sundsfjord A; Szabo D; Tambic-Andrasevic A; Vatcheva-Dobrevska R; Vitkauskiene A; Jeannot K
Article: JAC-ANTIMICROBIAL RESISTANCE. 2024;6(2):dlae039
Quality, availability and suitability of antimicrobial stewardship guidance: a multinational qualitative study
Linde-Ozola Z; Classen AY; Giske CG; Goepel S; Eliakim-Raz N; Semret M; Simonsen GS; Vehreschild JJ; Jorgensen SB; Kessel J; Kleppe LKS; Oma DH; Vehreschild MJGT; Vilde A; Dumpis U
Article: APMIS. 2024;132(2):94-99
Antimicrobial susceptibilities and genomic characteristics of methicillin-resistant Staphylococcus aureus resistant to mupirocin in Stockholm, Sweden
Vestberg N; Razavi M; Giske CG; Fang H
Article: APMIS. 2023;131(10):543-551
Performance of automated antimicrobial susceptibility testing for the detection of antimicrobial resistance in gram-negative bacteria: a NordicAST study
Leegaard TS; Justesen U; Matuschek EG; Giske C; NordicAST SGAAST
Article: JOURNAL OF CONTROLLED RELEASE. 2023;361:260-269
Therapeutic-oligonucleotides activated by nucleases (TOUCAN): A nanocarrier system for the specific delivery of clinical nucleoside analogues
Borsa BA; Hernandez LI; Jimenez T; Tellapragada C; Giske CG; Hernandez FJ
Article: INFECTION. 2023;51(4):1003-1012
Outcomes of octogenarians and nonactogenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study
Atamna A; Margalit I; Ayada G; Babich T; Naucler P; Valik JK; Giske CG; Benito N; Cardona R; Rivera A; Pulcini C; Fattah MA; Haquin J; Macgowan A; Chazan B; Yanovskay A; Ben Ami R; Landes M; Nesher L; Zaidman-Shimshovitz A; McCarthy K; Paterson DL; Tacconelli E; Buhl M; Mauer S; Rodriguez-Bano J; de Cueto M; Oliver A; Ruiz de Gopegui E; Cano A; Machuca I; Gozalo-Marguello M; Martinez-Martinez L; Gonzalez-Barbera EM; Gomez Alfaro I; Salavert M; Beovic B; Saje A; Mueller-Premru M; Pagani L; Vitrat V; Kofteridis D; Zacharioudaki M; Maraki S; Weissman Y; Paul M; Dickstei Y; Yahav D
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2023;42(8):1001-1009
Recurrent bacteremia with Enterococcus faecalis, the clinical findings predicting endocarditis, and genomic characterization of the isolates: a retrospective cohort study
Tellapragada C; Ostlund H; Giske C; Rasmussen M; Berge A
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2023;29(6):758-764
Towards clinical breakpoints for non-tuberculous mycobacteria-Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution
Froberg G; Maurer FP; Chryssanthou E; Fernstrom L; Benmansour H; Boarbi S; Mengshoel AT; Keller PM; Viveiros M; Machado D; Fitzgibbon MM; Mok S; Werngren J; Cirillo DM; Alcaide F; Hyyrylainen H-L; Aubry A; Andres S; Nadarajan D; Svensson E; Turnidge J; Giske CG; Kahlmeter G; Cambau E; van Ingen J; Schon T
Article: ANAEROBE. 2023;81:102743
Antimicrobial susceptibility testing of Bacteroides species by disk diffusion: The NordicAST Bacteroides study
Stubhaug TT; Giske CG; Justesen US; Kahlmeter G; Matuschek E; Sundsfjord A; Skaare D
Article: COMMUNICATIONS MEDICINE. 2023;3(1):31
Strain-level bacterial typing directly from patient samples using optical DNA mapping
Nyblom M; Johnning A; Frykholm K; Wrande M; Mueller V; Goyal G; Robertsson M; Dvirnas A; Sewunet T; Sriram KK; Ambjornsson T; Giske CG; Sandegren L; Kristiansson E; Westerlund F
Article: ELIFE. 2023;12:e82785
Network-based multi-omics integration reveals metabolic at-risk profile within treated HIV-infection
Mikaeloff F; Gelpi M; Benfeitas R; Knudsen AD; Vestad B; Hogh J; Hov JR; Benfield T; Murray D; Giske CG; Mardinoglu A; Troseid M; Nielsen SD; Neogi U; Hens N
Article: SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE. 2023;41(1):91-97
Agreement between rapid antigen detection test and culture for group A streptococcus in patients recently treated for pharyngotonsillitis-a prospective observational study in primary care
Rystedt K; Hedin K; Tyrstrup M; Skoog-Stahlgren G; Edlund C; Giske CG; Gunnarsson R; Sundvall P-D
Article: JAC-ANTIMICROBIAL RESISTANCE. 2022;5(1):dlad006
Effects of penicillin V on the faecal microbiota in patients with pharyngotonsillitis-an observational study
Rystedt K; Edquist P; Giske CG; Hedin K; Tyrstrup M; Stahlgren GS; Sundvall P-D; Edlund C
Article: JAC-ANTIMICROBIAL RESISTANCE. 2022;5(1):dlad004
Identification and characterization of plasmids carrying the mobile colistin resistance gene mcr-1 using optical DNA mapping
Sriram K; Wranne MS; Sewunet T; Ekedahl E; Coorens M; Tangkoskul T; Thamlikitkul V; Giske CG; Westerlund F
Journal article: OPEN FORUM INFECTIOUS DISEASES. 2022;9(Supplement_2):ofac492.595
542. Nanopore and Illumina sequencing for pathogen metagenomics and host transcriptomics of cerebrospinal fluid in infantile central nervous system infections
Horiba K; Torii Y; Yamaguchi M; Haruta K; Okumura T; Suzuki T; Kawano Y; Kawada J-I; Hara S; Giske C; Ogi T; Ito Y
Article: OPEN FORUM INFECTIOUS DISEASES. 2022;9(10):ofac504
Performance of Nanopore and Illumina Metagenomic Sequencing for Pathogen Detection and Transcriptome Analysis in Infantile Central Nervous System Infections
Horiba K; Torii Y; Aizawa Y; Yamaguchi M; Haruta K; Okumura T; Suzuki T; Kawano Y; Kawada J-I; Hara S; Saitoh A; Giske CG; Ogi T; Ito Y
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2022;60(4):106668
Isothermal microcalorimetry vs checkerboard assay to evaluate in-vitro synergism of meropenem-amikacin and meropenem-colistin combinations against multi-drug-resistant Gram-negative pathogens
Antonelli A; Coppi M; Tellapragada C; Hasan B; Maruri A; Gijon D; Morecchiato F; de Vogel C; Verbon A; van Wamel W; Kragh KN; Frimodt-Moller N; Canton R; Giske CG; Rossolini GM
Article: MICROORGANISMS. 2022;10(7):1470
Adaptation of Brucella melitensis Antimicrobial Susceptibility Testing to the ISO 20776 Standard and Validation of the Method
Tscherne A; Mantel E; Boskani T; Budniak S; Elschner M; Fasanella A; Feruglio SL; Galante D; Giske CG; Grunow R; Henczko J; Hinz C; Iwaniak W; Jacob D; Kedrak-Jablonska A; Jensen VK; Johansen TB; Kahlmeter G; Manzulli V; Matuschek E; Melzer F; Nuncio MS; Papaparaskevas J; Pelerito A; Solheim M; Thomann S; Tsakris A; Wahab T; Weiner M; Zoeller L; Zange S
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2022;41(7):1093-1098
Evaluation of a pneumonia multiplex PCR panel for detection of bacterial respiratory tract pathogens from serial specimens collected from hospitalized COVID-19 patients
Tellapragada C; Ydsten KA; Ternhag A; Giske CG
Article: SCIENTIFIC REPORTS. 2022;12(1):9301
A simple cut and stretch assay to detect antimicrobial resistance genes on bacterial plasmids by single-molecule fluorescence microscopy
Goyal G; Ekedahl E; Nyblom M; Krog J; Frobrant E; Brander M; Sewunet T; Tangkoskul T; Giske CG; Sandegren L; Thamlikitkul V; Ambjornsson T; Westerlund F
Article: INFECTION PREVENTION IN PRACTICE. 2022;4(2):100215
Molecular and genetic characterization of emerging carbapenemase-producing Acinetobacter baumannii strains from patients and hospital environments in Bangladesh
Farzana R; Swedberg G; Giske CG; Hasan B
Article: JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE. 2022;29:405-412
Polyclonal spread of bla_CTX-M-15 through high-risk clones of Escherichia coli at a tertiary hospital in Ethiopia
Sewunet T; Asrat D; Woldeamanuel Y; Ny S; Westerlund F; Aseffa A; Giske CG
Article: GENE. 2022;822:146355
Comprehensive pan-genomic, resistome and virulome analysis of clinical OXA-48 producing carbapenem-resistant Serratia marcescens strains
Bolourchi N; Goodarzi NNG; Giske CG; Nematzadeh S; Jouriani FH; Solgi H; Badmasti F
Article: CRITICAL CARE MEDICINE. 2022;50(5):825-836
Ventilator-Associated Lower Respiratory Tract Bacterial Infections in COVID-19 Compared With Non-COVID-19 Patients*
Hedberg P; Ternhag A; Giske CG; Stralin K; Ozenci V; Johansson N; Spindler C; Hedlund J; Martensson J; Naucler P
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2022;28(5):731.e1-731.e7
Blood culture diagnostics: a Nordic multicentre survey comparison of practices in clinical microbiology laboratories
Akerlund A; Petropoulos A; Malmros K; Tangden T; Giske CG
Article: BIOMEDICINES. 2022;10(5):982
Characterization of the Upper Respiratory Bacterial Microbiome in Critically Ill COVID-19 Patients
Bai X; Narayanan A; Skagerberg M; Cena-Diez R; Giske CG; Stralin K; Sonnerborg A
Article: BMC RESEARCH NOTES. 2022;15(1):113
Evaluation of multi-sample 16S ribosomal DNA sequencing for the diagnosis of postoperative bone and joint infections during antimicrobial treatment
Wallander K; Vondracek M; Giske CG
Article: JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE. 2022;28:254-263
Comparative resistome and virulome analysis of clinical NDM-1-producing carbapenem-resistant Enterobacter cloacae complex
Bolourchi N; Giske CG; Nematzadeh S; Mirzaie A; Abhari SS; Solgi H; Badmasti F
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2022;59(2):106496
High diversity of bla_NDM-1-encoding plasmids in Klebsiella pneumoniae isolated from neonates in a Vietnamese hospital
Sriram KK; Ekedahl E; Ngoc TBH; Sewunet T; Berglund B; Lundberg L; Nematzadeh S; Nilsson M; Nilsson LE; Le NK; Dien MT; Hanberger H; Olson L; Larsson M; Giske CG; Westerlund F
Article: FRONTIERS IN MICROBIOLOGY. 2022;13:951857
Molecular epidemiology and antimicrobial susceptibility of Pseudomonas spp. and Acinetobacter spp. from clinical samples at Jimma medical center, Ethiopia
Sewunet T; Asrat D; Woldeamanuel Y; Aseffa A; Giske CG
Article: PLOS ONE. 2022;17(10):e0274419
Fecal carriage and clonal dissemination of bla_NDM-1 carrying Klebsiella pneumoniae sequence type 147 at an intensive care unit in Lao PDR
Sewunet T; Sriram KK; Ha HN; Sithivong N; Ngoc TBH; Sychareun V; Nengmongvang K; Larsson M; Olson L; Westerlund F; Giske CG
Article: FRONTIERS IN PEDIATRICS. 2022;10:866762
Case Report: Fatal Outcome for a Preterm Newborn With Meningitis Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 1193
Oldendorff F; Linner A; Finder M; Eisenlauer P; Kjellberg M; Giske CG; Nordberg V
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2022;28(1):66-72
Clinical management of severe infections caused by carbapenem-resistant gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations
Carrara E; Savoldi A; Piddock LJV; Franceschi F; Ellis S; Sharland M; Brink AJ; Harris PNA; Levy-Hara G; Rohit A; Tsioutis C; Zayyad H; Giske C; Chiamenti M; Bragantini D; Righi E; Gorska A; Tacconelli E
Journal article: GENE REPORTS. 2021;25:101394
Genome analysis of an OXA-48-producing carbapenem- and colistin-resistant Klebsiella pneumoniae sequence type 11 clone isolated from an inpatient
Bolourchi N; Shahcheraghi F; Giske CG; Nematzadeh S; Solgi H; Badmasti F
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2021;40(12):2479-2485
The Unyvero Hospital-Acquired pneumonia panel for diagnosis of secondary bacterial pneumonia in COVID-19 patients
Tellapragada C; Giske CG
Article: EUROSURVEILLANCE. 2021;26(46):2002094
Staphylococcus aureus bloodstream infections: diverging trends of meticillin-resistant and meticillin-susceptible isolates, EU/EEA, 2005 to 2018
Gagliotti C; Hogberg LD; Billstrom H; Eckmanns T; Giske CG; Heuer OE; Jarlier V; Kahlmeter G; Wong DLF; Monen J; Murchan S; Simonsen GS; Subelj M; Andrasevic AT; Zabicka D; Zemlickova H; Monnet DL
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2021;65(12):e0106521-10.1128/aac.01021
Interactions of Polymyxin B in Combination with Aztreonam, Minocycline, Meropenem, and Rifampin against Escherichia coli Producing NDM and OXA-48-Group Carbapenemases
Olsson A; Hong M; Al-Farsi H; Giske CG; Lagerback P; Tangden T
Article: MICROBIOLOGY SPECTRUM. 2021;9(2):e0144021-e01421
In Vitro Activity of Omadacycline and Five Comparators against Contemporary Ribotypes of Clostridioides difficile in Stockholm, Sweden
Camporeale A; Tellapragada C; Kornijenko J; Nord CE; Giske CG
Article: ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS. 2021;20(1):74
Comparative genome analysis of colistin-resistant OXA-48-producing Klebsiellapneumoniae clinical strains isolated from two Iranian hospitals
Bolourchi N; Shahcheraghi F; Giske CG; Nematzadeh S; Goodarzi NN; Solgi H; Badmasti F
Article: MICROMACHINES. 2021;12(10):1234
A Parallelized Nanofluidic Device for High-Throughput Optical DNA Mapping of Bacterial Plasmids
Kk S; Lin Y-L; Sewunet T; Wrande M; Sandegren L; Giske CG; Westerlund F
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2021;40(9):1803-1813
A decade of neonatal sepsis caused by gram-negative bacilli-a retrospective matched cohort study
Nordberg V; Iversen A; Tidell A; Ininbergs K; Giske CG; Naver L
Article: ANTIBIOTICS. 2021;10(9):1029
Optical DNA Mapping of Plasmids Reveals Clonal Spread of Carbapenem-Resistant Klebsiella pneumoniae in a Large Thai Hospital
Kk S; Sewunet T; Wangchinda W; Tangkoskul T; Thamlikitkul V; Giske CG; Westerlund F
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2021;27(8):1172.e1-1172.e5
Revisiting colistin susceptibility testing: will adding calcium to Mueller-Hinton agar improve the detection of colistin resistance?
Matuschek E; Brolund A; Lindsjo OK; Giske CG; Byfors S; Kahlmeter G
Article: JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE. 2021;25:119-123
Epidemiological typing of ST80 vancomycin-resistant Enterococcus faecium : core genome multilocus sequence typing versus single nucleotide polymorphism-based typing
Dyrkell F; Giske CG; Fang H
Article: ACS INFECTIOUS DISEASES. 2021;7(5):1104-1115
Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine
Ray S; Narayanan A; Giske CG; Neogi U; Sonnerborg A; Nowak P
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2021;65(4):e02029-e02020
Poor Correlation between Meropenem and Piperacillin Plasma Concentrations and Delivered Dose of Continuous Renal Replacement Therapy
Petersson J; Giske CG; Eliasson E
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021;76(4):1001-1009
Effective antimicrobial combination in vivo treatment predicted with microcalorimetry screening
Kragh KN; Gijon D; Maruri A; Antonelli A; Coppi M; Kolpen M; Crone S; Tellapragada C; Hasan B; Radmer S; de Vogel C; van Wamel W; Verbon A; Giske CG; Rossolini GM; Canton R; Frimodt-Moller N
Article: EUROPEAN JOURNAL OF PEDIATRICS. 2021;180(3):893-898
Acute infection as cause of hospitalization of asylum-seeking children and adolescents in Stockholm, Sweden 2015-2016
Hertting O; Luthander J; Giske CG; Bennet R; Eriksson M
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2021;27(2):288.e1-288.e4
Multicentre testing of the EUCAST broth microdilution reference method for MIC determination on Mycobacterium tuberculosis
Schon T; Werngren J; Machado D; Borroni E; Wijkander M; Lina G; Mouton J; Matuschek E; Kahlmeter G; Giske C; Santin M; Cirillo DM; Viveiros M; Cambau E
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021;76(1):152-159
Determination of norvancomycin epidemiological cut-off values (ECOFFs) for Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus hominis.
Yang Q; Li X; Jia P; Giske C; Kahlmeter G; Turnidge J; Yu Y; Lv Y; Wang M; Sun Z; Lin J; Li Y; Zheng B; Hu F; Guo Y; Chen Z; Li H; Zhang G; Zhang J; Kang W; Duan S; Wang T; Jing R; Xu Y; Chinese Committee on Antimicrobial Susceptibility
Article: PLOS ONE. 2021;16(7):e0254805
High-risk clones of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolated from the University Hospital Establishment of Oran, Algeria (2011-2012)
Zemmour A; Dali-Yahia R; Maatallah M; Saidi-Ouahrani N; Rahmani B; Benhamouche N; Al-Farsi HM; Giske CG
Article: FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. 2021;11:599924
Systematic Comparison of Epidemic and Non-Epidemic Carbapenem Resistant Klebsiella pneumoniae Strains
Koskinen K; Penttinen R; Ormala-Odegrip A-M; Giske CG; Ketola T; Jalasvuori M
Article: JOURNAL OF HOSPITAL INFECTION. 2021;107:12-15
Genomic analysis revealed distinct transmission clusters of vancomycin-resistant Enterococcus faecium ST80 in Stockholm, Sweden
Fang H; Froding I; Ullberg M; Giske CG
Article: CLINICAL INFECTIOUS DISEASES. 2020;71(9):e523-e529
Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing Position Statements on Polymyxin B and Colistin Clinical Breakpoints
Satlin MJ; Lewis JSII; Weinstein MP; Patel J; Humphries RM; Kahlmeter G; Giske CG; Turnidge J
Article: PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2020;39(12):1069-1074
Trends of Pediatric Bloodstream Infections in Stockholm, Sweden: A 20-year Retrospective Study
Luthander J; Bennet R; Giske CG; Eriksson M; Nilsson A
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2020;64(12):e01585-e01520
A Cross-Sectional Cohort Study of Extended-Spectrum-Beta-Lactamase-Producing Enterobacterales in Patients with Traveler's Diarrhea
Ljungquist O; Camporeale A; Nematzadeh S; Giske CG; Resman F; Riesbeck K; Tham J
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2020;26(11):1488-1492
Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates - the EUCAST broth microdilution reference method for MIC determination
Schon T; Werngren J; Machado D; Borroni E; Wijkander M; Lina G; Mouton J; Matuschek E; Kahlmeter G; Giske C; Santin M; Cirillo DM; Viveiros M; Cambau E
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2020;75(10):2804-2811
Optical maps of plasmids as a proxy for clonal spread of MDR bacteria: a case study of an outbreak in a rural Ethiopian hospital
Lin Y-L; Sewunet T; Sriram KK; Giske CG; Westerlund F
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2020;26(10):1413.e1-1413.e7
Isothermal microcalorimetry minimal inhibitory concentration testing in extensively drug resistant Gram-negative bacilli: a multicentre study
Tellapragada C; Hasan B; Antonelli A; Maruri A; de Vogel C; Gijon D; Coppi M; Verbon A; van Wamel W; Rossolini GM; Canton R; Giske CG
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2020;26(8):1039-1043
Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper
Turnidge J; Kahlmeter G; Canton R; MacGowan A; Giske CG
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2020;64(8):e02351-e02319
Extended-Spectrum-β-Lactamase- and Plasmid AmpC-Producing Escherichia coli Causing Community-Onset Bloodstream Infection: Association of Bacterial Clones and Virulence Genes with Septic Shock, Source of Infection, and Recurrence
Froding I; Hasan B; Sylvin I; Coorens M; Naucler P; Giske CG
Article: CLINICAL INFECTIOUS DISEASES. 2020;70(11):2270-2280
Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective Study
Babich T; Naucler P; Karlsson Valik J; Giske CG; Benito N; Cardona R; Rivera A; Pulcini C; Fattah MA; Haquin J; Macgowan A; Grier S; Gibbs J; Chazan B; Yanovskay A; Ben Ami R; Landes M; Nesher L; Zaidman-Shimshovitz A; McCarthy K; Paterson DL; Tacconelli E; Buhl M; Mauer S; Rodriguez-Bano J; Morales I; Oliver A; De Gopegui ER; Cano A; Machuca I; Gozalo-Marguello M; Martinez Martinez L; Gonzalez-Barbera EM; Gomez Alfaro I; Salavert M; Beovic B; Saje A; Mueller-Premru M; Pagani L; Vitrat V; Kofteridis D; Zacharioudaki M; Maraki S; Weissman Y; Paul M; Dickstein Y; Leibovici L; Yahav D
Article: ACS INFECTIOUS DISEASES. 2020;6(5):1076-1084
Cultivation-Free Typing of Bacteria Using Optical DNA Mapping
Muller V; Nyblom M; Johnning A; Wrande M; Dvirnas A; Sriram KK; Giske CG; Ambjornsson T; Sandegren L; Kristiansson E; Westerlund F
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2020;55(2):105847
Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study
Babich T; Naucler P; Valik JK; Giske CG; Benito N; Cardona R; Rivera A; Pulcini C; Fattah MA; Haquin J; MacGowan A; Grier S; Chazan B; Yanovskay A; Ben Ami R; Landes M; Nesher L; Zaidman-Shimshovitz A; McCarthy K; Paterson DL; Tacconelli E; Buhl M; Maurer S; Rodriguez-Bano J; Morales I; Oliver A; Ruiz de Gopegui E; Cano A; Machuca I; Gozalo-Marguello M; Martinez-Martinez L; Gonzalez-Barbera EM; Gomez Alfaro I; Salavert M; Beovic B; Saje A; Mueller-Premru M; Pagani L; Vitrat V; Kofteridis D; Zacharioudaki M; Maraki S; Weissman Y; Paul M; Dickstein Y; Leibovici L; Yahav D
Article: EUROSURVEILLANCE. 2020;25(2):39-51
Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016
Beeton ML; Zhang X-S; Uldum SA; Bebear C; Dumke R; Gullsby K; Ieven M; Loens K; Nir-Paz R; Pereyre S; Spiller OB; Chalker VJ; Bossuyt N; Lagrou K; Mitis G; Koliou M; Havlickova M; Kyncl J; Emborg H-D; Voldstedlund M; MacKenzie CR; Maltezou HC; Georgakopoulou T; Petridou E; Banou K; Balla E; Connell J; Yandle Z; Moran J; Burns K; Michael-Gayego A; Moses AE; Fenech TM; Anestad G; Blystad H; Vestrheim DF; Froes F; Kese D; Socan M; Cano Portero R; Santos Sanz S; Suarez Rodriguez B; Ternhag A; Giske C; Wisell KT; Marques DP; Reynolds A; McMenamin J
Article: PLOS ONE. 2020;15(10):e0239924
Clinical and molecular characteristics of carbapenem non-susceptibleEscherichia coli: A nationwide survey from Oman
Al-Farsi HM; Camporeale A; Ininbergs K; Al-Azri S; Al-Muharrmi Z; Al-Jardani A; Giske CG
Article: PLOS ONE. 2020;15(11):e0242533
Low prevalence of bloodstream infection and high blood culture contamination rates in patients with COVID-19
Yu D; Ininbergs K; Hedman K; Giske CG; Stralin K; Ozenci V
Article: FRONTIERS IN MICROBIOLOGY. 2020;11:936
Molecular Epidemiology of OXA-48 and NDM-1 Producing Enterobacterales Species at a University Hospital in Tehran, Iran, Between 2015 and 2016
Solgi H; Nematzadeh S; Giske CG; Badmasti F; Westerlund F; Lin Y-L; Goyal G; Nikbin VS; Nemati AH; Shahcheraghi F
Article: PLOS ONE. 2020;15(3):e0230501
Low incidence of antibiotic-resistant bacteria in south-east Sweden: An epidemiologic study on 9268 cases of bloodstream infection
Holmbom M; Moller V; Nilsson LE; Giske CG; Rashid M-U; Fredrikson M; Hallgren A; Hanberger H; Balkhed AO
Article: INFECTION AND IMMUNITY. 2019;88(1):e00756-e00719
Klebsiella pneumoniae Expressing VIM-1 Metallo-β-Lactamase Is Resensitized to Cefotaxime via Thiol-Mediated Zinc Chelation
Karadottir H; Coorens M; Liu Z; Wang Y; Agerberth B; Giske CG; Bergman P
Journal article: JOURNAL OF RADIOLOGY NURSING. 2019;38(4):254-260
Surface Contamination of CT and MRI Equipment—A Potential Source for Transmission of Hospital-Acquired Infections
Palmqvist C; Samuelsson A; Fröding I; Giske CG
Article: NATURE MICROBIOLOGY. 2019;4(11):1919-1929
Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread
David S; Reuter S; Harris SR; Glasner C; Feltwell T; Argimon S; Abudahab K; Goater R; Giani T; Errico G; Aspbury M; Sjunnebo S; Feil EJ; Rossolini GM; Aanensen DM; Grundmann H; Koraqi A; Lacej D; Apfalter P; Hartl R; Glupczynski Y; Huang T-D; Strateva T; Marteva-Proevska Y; Tambic Andrasevic A; Butic I; Pieridou-Bagatzouni D; Maikanti-Charalampous P; Hrabak J; Zemlickova H; Hammerum A; Jakobsen L; Ivanova M; Pavelkovich A; Jalava J; Osterblad M; Dortet L; Vaux S; Kaase M; Gatermann SG; Vatopoulos A; Tryfinopoulou K; Toth A; Janvari L; Boo TW; McGrath E; Carmeli Y; Adler A; Pantosti A; Monaco M; Raka L; Kurti A; Balode A; Saule M; Miciuleviciene J; Mierauskaite A; Perrin-Weniger M; Reichert P; Nestorova N; Debattista S; Mijovic G; Lopicic M; Samuelsen O; Haldorsen B; Zabicka D; Literacka E; Canica M; Manageiro V; Kaftandzieva A; Trajkovska-Dokic E; Damian M; Lixandru B; Jelesic Z; Trudic A; Niks M; Schreterova E; Pirs M; Cerar T; Oteo J; Aracil B; Giske C; Sjostrom K; Gur D; Cakar A; Woodford N; Hopkins K; Wiuff C; Brown DJ
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2019;25(11):1408-1414
Risk factors for community-onset bloodstream infection with extended-spectrum β-lactamase-producing Enterobacteriaceae: national population-based case-control study
Isendahl J; Giske CG; Wisell KT; Ternhag A; Naucler P
Article: THE BMJ. 2019;367:l5337
Penicillin V four times daily for five days versus three times daily for 10 days in patients with pharyngotonsillitis caused by group A streptococci: randomised controlled, open label, non-inferiority study
Stahlgren GS; Tyrstrup M; Edlund C; Giske CG; Molstad S; Norman C; Rystedt K; Sundvall P-D; Hedin K
Article: OPEN FORUM INFECTIOUS DISEASES. 2019;6(10):ofz437
Risk for Endocarditis in Bacteremia With Streptococcus-Like Bacteria: A Retrospective Population-Based Cohort Study
Berge A; Kronberg K; Sunnerhagen T; Nilson BHK; Giske CG; Rasmussen M
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2019;25(10):1289.e5-1289.e8
Transmission events and antimicrobial susceptibilities of methicillin-resistant Staphylococcus argenteus in Stockholm
Giske CG; Dyrkell F; Arnellos D; Vestberg N; Panna SH; Froding I; Ullberg M; Fang H
Article: CLINICAL INFECTIOUS DISEASES. 2019;69(8):1394-1402
Minimum Inhibitory Concentrations of Fluoroquinolones and Pyrazinamide Susceptibility Correlate to Clinical Improvement in Multidrug-resistant Tuberculosis Patients: A Nationwide Swedish Cohort Study Over 2 Decades
Forsman LD; Jonsson J; Wagrell C; Werngren J; Mansjo M; Wijkander M; Groenheit R; Hammar U; Giske CG; Schon T; Bruchfeld J
Article: EUROSURVEILLANCE. 2019;24(33):7-16
Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016
Jarlier V; Hogberg LD; Heuer OE; Campos J; Eckmanns T; Giske CG; Grundmann H; Johnson AP; Kahlmeter G; Monen J; Pantosti A; Rossolini GM; van de Sande-Bruinsma N; Vatopoulos A; Zabicka D; Zemlickova H; Monnet DL; Simonsen GS; Strauss R; Mertens K; Marteva-Proevska YS; Soprek S; Maikanti-Charalampous P; Jakubu V; Sonksen U; Ivanova M; Maugat S; Jalava J; Noll I; Polemis M; Vegh Z; Kristinsson KG; Murchan S; Balode AO; Miciuleviciene J; Perrin M; Woudt SHS; Gran FW; Hryniewicz W; Canica M; Niculcea AS; Schreterova E; Subelj M; Aracil B; Billstrom H; Anderson E
Article: SCIENTIFIC REPORTS. 2019;9(1):10291
Genome and plasmid diversity of Extended-Spectrum β-Lactamase-producing Escherichia coli ST131-tracking phylogenetic trajectories with Bayesian inference
Ny S; Sandegren L; Salemi M; Giske CG
Article: MBIO. 2019;10(4):e00347-e00319
Optical DNA Mapping Combined with Cas9-Targeted Resistance Gene Identification for Rapid Tracking of Resistance Plasmids in a Neonatal Intensive Care Unit Outbreak
Bikkarolla SK; Nordberg V; Rajer F; Mueller V; Kabir MH; Sriram KK; Dvirnas A; Ambjornsson T; Giske CG; Naver L; Sandegren L; Westerlund F
Article: JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE. 2019;17:25-34
Antimicrobial resistance of Escherichia coli isolates from outpatient urinary tract infections in women in six European countries including Russia
Ny S; Edquist P; Dumpis U; Grondahl-Yli-Hannuksela K; Hermese J; Kling A-M; Klingeberg A; Kozlov R; Kallman O; Lis DO; Pomorska-Wesolowska M; Saule M; Wisell KT; Vuopio J; Palagin I; Rantakokko-Jalava K; Laine M; Wuorela M; Marttila J; Eckmanns T; Abu Sin M; Velasco E; Willrich N; Feig M; Noll I; Oberdorfer K; Krenz-Weinreich A; Emrich D; Zill E; Kalka-Moll W; Wichmann O; Ivanchik N; Dyar O; Giske C; Brewczynski PZ; Horon L
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2019;53(6):820-829
Prediction of bloodstream infection caused by extended-spectrum β-lactamase-producing Enterobacterales in patients with suspected community-onset sepsis
Froding I; Valik JK; Bolinder L; Naucler P; Giske CG
Article: EUROSURVEILLANCE. 2019;24(20):6-12
Lyme neuroborreliosis epidemiology in Sweden 2010 to 2014: clinical microbiology laboratories are a better data source than the hospital discharge diagnosis register
Dahl V; Wisell KT; Giske CG; Tegnell A; Wallensten A
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2019;63(4):e02201-e02218
Dynamics of Resistance Plasmids in Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae during Postinfection Colonization
Brolund A; Rajer F; Giske CG; Melefors O; Titelman E; Sandegren L
Article: CLINICAL INFECTIOUS DISEASES. 2019;68(4):641-649
Temporal Dynamics and Risk Factors for Bloodstream Infection With Extended-spectrum β-Lactamase-producing Bacteria in Previously-colonized Individuals: National Population-based Cohort Study
Isendahl J; Giske CG; Hammar U; Sparen P; Wisell KT; Ternhag A; Naucler P
Article: LAKARTIDNINGEN. 2019;116:FHCX
[A new SIR definition for antimicrobial susceptibility testing].
Giske C; Hanberger H; Kahlmeter G
Article: FRONTIERS IN MICROBIOLOGY. 2019;10:1372
Two FtsH Proteases Contribute to Fitness and Adaptation of Pseudomonas aeruginosa Clone C Strains
Kamal SM; Rybtke ML; Nimtz M; Sperlein S; Giske C; Trcek J; Deschamps J; Briandet R; Dini L; Jaensch L; Tolker-Nielsen T; Lee C; Romling U
Article: FRONTIERS IN MICROBIOLOGY. 2019;10:2632
Effects of the Antimicrobial Peptide LL-37 and Innate Effector Mechanisms in Colistin-Resistant Klebsiella pneumoniae With mgrB Insertions
Al-Farsi HM; Al-Adwani S; Ahmed S; Vogt C; Ambikan AT; Leber A; Al-Jardani A; Al-Azri S; Al-Muharmi Z; Toprak MS; Giske CG; Bergman P
Journal article: ИНФЕКЦИЯ И ИММУНИТЕТ. 2018;8(4):563-564
MOLECULAR TYPING OF MYCOBACTERIUM KANSASII — A GLOBAL PERSPECTIVE
Bakuła Z; Arias F; Bachiyska E; Borroni E; Cirillo DM; Coulter C; Giske C; Humięcka J; van Ingen J; Ioannidis P; Kranzer K; Kuzmič U; Levina K; Lillebæk T; Mokrousov I; Morimoto K; Nikolayevskyy V; Norman A; Papaventsis D; Peuchant O; Safianowska A; Ulmann V; Vasiliauskiene E; Won-Jung K; Zhuravlev V; Žolnir-Dovč M; Krenke R; Jagielski T
Journal article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018;73(10):2905
Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study.
Haldorsen B; Giske CG; Hansen DS; Orri Helgason K; Kahlmeter G; Löhr IH; Matuschek E; Österblad M; Rantakokko-Jalava K; Wang M; Småbrekke L; Samuelsen Ø; Sundsfjord A
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018;73(10):2738-2747
Performance of the EUCAST disc diffusion method and tw MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study
Haldorsen B; Giske CG; Hansen DS; Helgason KO; Kahlmeter G; Lohr IH; Matuschek E; Osterblad M; Rantakokko-Jalava K; Wang M; Smabrekke L; Samuelsen O; Sundsfjord A
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2018;24(9):1004-1009
Neonatal intestinal colonization with extended-spectrum β-lactamase-eproducing Enterobacteriaceae-a 5-year follow-up study
Nordberg V; Jonsson K; Giske CG; Iversen A; Aspevall O; Jonsson B; Camporeale A; Norman M; Naver L
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018;73(6):1517-1524
Molecular epidemiology of NDM-1-and OXA-48-producing Klebsiella pneumoniae in an Iranian hospital: clonal dissemination of ST11 and ST893
Solgi H; Badmasti F; Giske CG; Aghamohammad S; Shahcheraghi F
Article: BMC INFECTIOUS DISEASES. 2018;18(1):233
Infection with high proportion of multidrug-resistant bacteria in conflict-related injuries is associated with poor outcomes and excess resource consumption: a cohort study of Syrian patients treated in Jordan
Alga A; Wong S; Shoaib M; Lundgren K; Giske CG; von Schreeb J; Malmstedt J
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018;73(3):564-568
MIC-based dose adjustment: facts and fables
Mouton JW; Muller AE; Canton R; Giske CG; Kahlmeter G; Turnidge J
Article: THE LANCET INFECTIOUS DISEASES. 2018;18(3):318-327
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Tacconelli E; Carrara E; Savoldi A; Harbarth S; Mendelson M; Monnet DL; Pulcini C; Kahlmeter G; Kluytmans J; Carmeli Y; Ouellette M; Outterson K; Patel J; Cavaleri M; Cox EM; Houchens CR; Grayson ML; Hansen P; Singh N; Theuretzbacher U; Magrini N; WHO Pathogens Priority List Working Group
Article: PLOS ONE. 2018;13(4):e0195258
Invasive infection caused by Klebsiella pneumoniae is a disease affecting patients with high comorbidity and associated with high long-term mortality
Vading M; Naucler P; Kalin M; Giske CG
Article: PLOS ONE. 2018;13(2):e0192782
Introduction of a hydrolysis probe PCR assay for high-throughput screening of methicillin-resistant Staphylococcus aureus with the ability to include or exclude detection of Staphylococcus argenteus
Bogestam K; Vondracek M; Karlsson M; Fang H; Giske CG
Article: PLOS ONE. 2018;13(11):e0205761
USA300 methicillin-resistant Staphylococcus aureus in Stockholm, Sweden, from 2008 to 2016
Enstrom J; Froding I; Giske CG; Ininbergs K; Bai X; Sandh G; Tollstrom U-B; Ullberg M; Fang H
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2017;36(11):2127-2135
Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla _NDM-7 and bla _OXA-48
Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
Article: INFECTION, GENETICS AND EVOLUTION. 2017;55:318-323
Emergence of carbapenem resistant Escherichia coli isolates producing bla_NDM and bla_OXA-48-like carried on IncA/C and IncL/M plasmids at two Iranian university hospitals
Solgi H; Giske CG; Badmasti F; Aghamohammad S; Havaei SA; Sabeti S; Mostafavizadeh K; Shahcheraghi F
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2017;72(4):1094-1102
Rapid EUCAST disc diffusion testing of MDR Escherichia coli and Klebsiella pneumoniae: inhibition zones for extended-spectrum cephalosporins can be reliably read after 6 h of incubation
Froeding I; Vondracek M; Giske CG
Article: THE LANCET INFECTIOUS DISEASES. 2017;17(2):153-163
Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study
Grundmann H; Glasner C; Albiger B; Aanensen DM; Tomlinson CT; Tambic Andrasevic A; Canton R; Carmeli Y; Friedrich AW; Giske CG; Glupczynski Y; Gniadkowski M; Livermore DM; Nordmann P; Poirel L; Rossolini GM; Seifert H; Vatopoulos A; Walsh T; Woodford N; Monnet DL; Apfalter P; Hartl R; Glupczynski Y; Huang T-D; Strateva T; Marteva-Proevska Y; Andrasevic AT; Butic I; Pieridou-Bagatzouni D; Maikanti-Charalampous P; Hrabak J; Zemlickova H; Hammerum A; Jakobsen L; Ivanova M; Pavelkovich A; Jalava J; Osterblad M; Vaux S; Dortet L; Kaase M; Gatermann SG; Vatopoulos A; Tryfinopoulou K; Toth A; Janvari L; Boo TW; McGrath E; Pantosti A; Monaco M; Balode A; Saule M; Miciuleviciene J; Mierauskaite A; Perrin-Weniger M; Reichert P; Nestorova N; Debattista S; Zabicka D; Literacka E; Canica M; Manageiro V; Damian M; Lixandru B; Niks M; Schreterova E; Pirs M; Cerar T; Oteo J; Aracil B; Giske CG; Sjostrom K; Woodford N; Hopkins K; Wiuff C; Brown DJ; Hardarson H; Samuelsen O; Haldorsen B; Koraqi A; Lacej D; Raka L; Kurti A; Mijovic G; Lopicic M; Jelesic Z; Trudic A; Kraftandzieva A; Trajkovska-Dokic E; Gur D; Cakar A; Carmeli Y; Adler A
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2017;72(2):582-588
Community carriage of ESBL-producing Escherichia coli is associated with strains of low pathogenicity: a Swedish nationwide study
Ny S; Lofmark S; Borjesson S; Englund S; Ringman M; Bergstrom J; Naucler P; Giske CG; Byfors S
Journal article: OPEN FORUM INFECTIOUS DISEASES. 2016;3(suppl_1):1100
14-Year Survey in a Swedish County Reveals an Alarming Increase in Bloodstream Infections (BSI). Comorbidity: An Independent Risk Factor for Both BSI and Mortality
Holmbom M; Giske C; Nilsson LE; Hoffmann M; Fredriksson M; Claesson C; Östholm-Balkhed Å; Hanberger H
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2016;71(12):3548-3555
Frequent acquisition of low-virulence strains of ESBL-producing Escherichia coli in travellers
Vading M; Kabir MH; Kalin M; Iversen A; Wiklund S; Naucler P; Giske CG
Article: ACTA ANAESTHESIOLOGICA SCANDINAVICA. 2016;60(10):1425-1436
Standard dosing of piperacillin and meropenem fail to achieve adequate plasma concentrations in ICU patients
Petersson J; Giske CG; Eliasson E
Article: BMC INFECTIOUS DISEASES. 2016;16(1):484
A randomized controlled study of 5 and 10 days treatment with phenoxymethylpenicillin for pharyngotonsillitis caused by streptococcus group A - a protocol study
Skoog G; Edlund C; Giske CG; Molstad S; Norman C; Sundvall P-D; Hedin K
Article: INFECTIOUS DISEASES. 2016;48(8):618-625
Etiology of bone and joint infections: a case series of 363 consecutive patients from an orthopaedic infection unit
Wallander K; Jorup-Ronstrom C; Ullberg M; Tornblom I; Ottosson C; Giske CG
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2016;71(8):2321-2325
Evaluation of antibacterial activities of colistin, rifampicin and meropenem combinations against NDM-1-producing Klebsiella pneumoniae in 24 h in vitro time-kill experiments
Lagerback P; Khine WWT; Giske CG; Tangden T
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2016;71(5):1213-1216
A two-centre evaluation of RAPIDEC® CARBA NP for carbapenemase detection in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp.
Kabir MH; Meunier D; Hopkins KL; Giske CG; Woodford N
Article: ANNALS OF HEMATOLOGY. 2016;95(6):871-879
Bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal single-center study
Kjellander C; Bjorkholm M; Kallman O; Giske CG; Weibull CE; Love TJ; Landgren O; Kristinsson SY
Article: SCIENTIFIC REPORTS. 2016;6:23532
Metagenomic analysis of bloodstream infections in patients with acute leukemia and therapy-induced neutropenia
Gyarmati P; Kjellander C; Aust C; Song Y; Ohrmalm L; Giske CG
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2016;71(2):333-338
Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB
Niward K; Angeby K; Chryssanthou E; Paues J; Bruchfeld J; Jureen P; Giske CG; Kahlmeter G; Schon T
Article: PLOS ONE. 2016;11(7):e0159694
The IRIDICA PCR/Electrospray Ionization-Mass Spectrometry Assay on Bronchoalveolar Lavage for Bacterial Etiology in Mechanically Ventilated Patients with Suspected Pneumonia
Stralin K; Ehn F; Giske CG; Ullberg M; Hedlund J; Petersson J; Spindler C; Ozenci V
Article: PLOS ONE. 2016;11(11):e0166527
14-Year Survey in a Swedish County Reveals a Pronounced Increase in Bloodstream Infections (BSI). Comorbidity - An Independent Risk Factor for Both BSI and Mortality
Holmbom M; Giske CG; Fredrikson M; Balkhed AO; Claesson C; Nilsson LE; Hoffmann M; Hanberger H
Article: DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2015;83(4):371-374
Successful international clones of bla_CTX-M-15-producing Klebsiella pneumoniae with coexpression of plasmid-mediated quinolone resistance (PMQR) determinants in Tehran hospitals
Nematzadeh S; Shahcheraghi F; Iversen A; Giske CG
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2015;104(9):933-939
The aetiology of paediatric bloodstream infections changes after pneumococcal vaccination and group B streptococcus prophylaxis
Luthander J; Bennet R; Giske CG; Nilsson A; Eriksson M
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2015;70(8):2177-2181
Reviving old antibiotics
Theuretzbacher U; Van Bambeke F; Canton R; Giske CG; Mouton JW; Nation RL; Paul M; Turnidge JD; Kahlmeter G
Article: PROSTATE. 2015;75(9):947-956
Rapid Increase in Multidrug-Resistant Enteric Bacilli Blood Stream Infection After Prostate Biopsy-A 10-Year Population-Based Cohort Study
Aly M; Dyrdak R; Nordstrom T; Jalal S; Weibull CE; Giske CG; Gronberg H
Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2015;43(3):302-308
Knowledge and understanding of antibiotic resistance and the risk of becoming a carrier when travelling abroad: A qualitative study of Swedish travellers
Wiklund S; Fagerberg I; Ortqvist A; Vading M; Giske CG; Broliden K; TAmmelin A
Article: INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY. 2015;4 Suppl 1:80-81
Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.
Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K
Article: LAKARTIDNINGEN. 2015;112:C73S
[Response times can be shortened in microbiological diagnosis of sepsis. Better opening hours in laboratories and active advice enables faster therapy].
Åkerlund A; Sundqvist M; Hanberger H; Åhrén C; Serrander L; Giske CG
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2015;21(2):148.e5-148.e7
Little difference between minimum inhibitory concentrations of Mycobacterium tuberculosis wild-type organisms determined with BACTEC MGIT 960 and Middlebrook 7H10
Sturegard E; Angeby KA; Werngren J; Jureen P; Kronvall G; Giske CG; Kahlmeter G; Schon T
Article: EUROSURVEILLANCE. 2015;20(2):21008-28
Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe
Brown D; Canton R; Dubreuil L; Gatermann S; Giske C; MacGowan A; Martinez-Martinez L; Mouton J; Skov R; Steinbakk M; Walton C; Heuer O; Struelens MJ; Hogberg LD; Kahlmeter G
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2015;45(1):25-32
Surveillance of antimicrobial resistance among Escherichia coli in wastewater in Stockholm during 1 year: does it reflect the resistance trends in the society?
Kwak Y-K; Colque P; Byfors S; Giske CG; Mollby R; Kuhn I
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2015;59(6):3630-3632
Meropenem-Clavulanic Acid Has High In Vitro Activity against Multidrug-Resistant Mycobacterium tuberculosis
Forsman LD; Giske CG; Bruchfeld J; Schon T; Jureen P; Angeby K
Article: PLOS ONE. 2015;10(8):e0135756
Bacterial Landscape of Bloodstream Infections in Neutropenic Patients via High Throughput Sequencing
Gyarmati P; Kjellander C; Aust C; Kalin M; Ohrmalm L; Giske CG
Article: BMC INFECTIOUS DISEASES. 2014;14:3859
Prevalence of community-acquired bacteraemia in Guinea-Bissau: an observational study
Isendahl J; Manjuba C; Rodrigues A; Xu W; Henriques-Normark B; Giske CG; Naucler P
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2014;58(12):7557-7559
Intra- and Extracellular Activities of Trimethoprim-Sulfamethoxazole against Susceptible and Multidrug-Resistant Mycobacterium tuberculosis
Forsman LD; Scohn T; Simonsson USH; Bruchfeld J; Larsson M; Jureen P; Sturegard E; Giske CG; Angeby K
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2014;103(8):856-861
Subnormal levels of vitamin D are associated with acute wheeze in young children
Hammar KS; Hedlin G; Konradsen JR; Nordlund B; Kull I; Giske CG; Pedroletti C; Soderhall C; Melen E
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2014;20(8):O508-O515
Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors
Titelman E; Hasan CM; Iversen A; Naucler P; Kais M; Kalin M; Giske CG
Journal article: LAKARTIDNINGEN. 2014;111(24):1050-1051
[New antibiotics with activity against multidrug-resistant enterobacteriaceae. Combination preparations are now being tested clinically].
Petropoulos EA; Hanberger H; Giske CG
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2014;20(6):O344-O352
Epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in Sweden 2007-2011
Brolund A; Edquist PJ; Makitalo B; Olsson-Liljequist B; Soderblom T; Wisell KT; Giske CG
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2014;52(5):1582-1589
Performance of the EUCAST Disk Diffusion Method, the CLSI Agar Screen Method, and the Vitek 2 Automated Antimicrobial Susceptibility Testing System for Detection of Clinical Isolates of Enterococci with Low- and Medium-Level VanB-Type Vancomycin Resistance: a Multicenter Study
Hegstad K; Giske CG; Haldorsen B; Matuschek E; Schonning K; Leegaard TM; Kahlmeter G; Sundsfjord A
Article: BMC MICROBIOLOGY. 2014;14:89
The detection and verification of carbapenemases using ertapenem and Matrix Assisted Laser Desorption Ionization-Time of Flight
Johansson A; Ekelof J; Giske CG; Sundqvist M
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2014;33(3):399-409
Occurrence of virulence genes, 16S rRNA methylases, and plasmid-mediated quinolone resistance genes in CTX-M-producing Escherichia coli from Pakistan
Habeeb MA; Haque A; Iversen A; Giske CG
Article: LAKARTIDNINGEN. 2014;111(7):268-269
[Aminoglycosides are effective--but oto- and nephrotoxic. Knowledge base from the reference group for antibiotic issues on benefit-risk with aminoglycosides].
Ternhag A; Giske CG; Hanberger H
Article: PLOS ONE. 2014;9(7):e103610
Nuclease-Assisted Suppression of Human DNA Background in Sepsis
Song Y; Giske CG; Gille-Johnson P; Emanuelsson O; Lundeberg J; Gyarmati P
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2014;58(3):1757-1762
Evaluation of Double- and Triple-Antibiotic Combinations for VIM- and NDM-Producing Klebsiella pneumoniae by In Vitro Time-Kill Experiments
Tangden T; Hickman RA; Forsberg P; Lagerback P; Giske CG; Cars O
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2014;20(1):34-37
Dissemination of bla_VIM in Greece at the peak of the epidemic of 2005-2006: clonal expansion of Klebsiella pneumoniae clonal complex 147
Hasan CM; Turlej-Rogacka A; Vatopoulos AC; Giakkoupi P; Maatallah M; Giske CG
Article: PLOS ONE. 2014;9(11):e113539
Klebsiella variicola Is a Frequent Cause of Bloodstream Infection in the Stockholm Area, and Associated with Higher Mortality Compared to K. pneumoniae
Maatallah M; Vading M; Kabir MH; Bakhrouf A; Kalin M; Naucler P; Brisse S; Giske CG
Article: CURRENT MICROBIOLOGY. 2013;67(6):712-717
Attachment and Biofilm Forming Capabilities of Staphylococcus epidermidis Strains Isolated from Preterm Infants
Hell E; Giske CG; Hultenby K; Danielsson KG; Marchini G
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2013;68(9):2074-2077
Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
Schon T; Jureen P; Chryssanthou E; Giske CG; Kahlmeter G; Hoffner S; Angeby K
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2013;32(9):1205-1210
Phenotypic detection of plasmid-acquired AmpC in Escherichia coli-evaluation of screening criteria and performance of two commercial methods for the phenotypic confirmation of AmpC production
Edquist P; Ringman M; Liljequist BO; Wisell KT; Giske CG
Article: LAKARTIDNINGEN. 2013;110(32-33):1398
[ESBL-CARBA can become a problem in Swedish health care].
Giske CG; Kalin M
Article: EUROSURVEILLANCE. 2013;18(28):20525
Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013.
Glasner C; Albiger B; Buist G; Tambić Andrasević A; Canton R; Carmeli Y; Friedrich AW; Giske CG; Glupczynski Y; Gniadkowski M; Livermore DM; Nordmann P; Poirel L; Rossolini GM; Seifert H; Vatopoulos A; Walsh T; Woodford N; Donker T; Monnet DL; Grundmann H; European Survey on Carbapenemase-Producing Enterob
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2013;41(6):524-526
High prevalence of 16S rRNA methylase RmtB among CTX-M extended-spectrum β-lactamase-producing Klebsiella pneumoniae from Islamabad, Pakistan
Habeeb MA; Haque A; Nematzadeh S; Iversen A; Giske CG
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2013;45(4):285-291
Bacteremia in Swedish hematological patients with febrile neutropenia: Bacterial spectrum and antimicrobial resistance patterns
Aust C; Tolfvenstam T; Broliden K; Ljungman P; Kalin M; Giske CG; Ohrmalm L
Article: APMIS. 2013;121(2):146-152
A multiresistant clone of Pseudomonas aeruginosa sequence type 773 spreading in a burn unit in Orumieh, Iran
Yousefi S; Nahaei MR; Farajnia S; Aghazadeh M; Iversen A; Edquist P; Maatallah M; Giske CG
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2013;102(2):182-186
Age and risk factors influence the microbial aetiology of bloodstream infection in children
Luthander J; Bennet R; Giske CG; Nilsson A; Eriksson M
Journal article: EUROSURVEILLANCE. 2013;18(28):9-15
Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013
Glasner C; Albiger B; Buist G; Tambic Andrasevic A; Canton R; Carmeli Y; Friedrich AW; Giske CG; Glupczynski Y; Gniadkowski M; Livermore DM; Nordmann P; Poirel L; Rossolini GM; Seifert H; Vatopoulos A; Walsh T; Woodford N; Donker T; Monnet DL; Grundmann H
Article: PLOS ONE. 2013;8(10):e76597
High Proportion of Intestinal Colonization with Successful Epidemic Clones of ESBL-Producing Enterobacteriaceae in a Neonatal Intensive Care Unit in Ecuador
Nordberg V; Peralta AQ; Galindo T; Turlej-Rogacka A; Iversen A; Giske CG; Naver L
Article: APMIS. 2013;121(1):72-78
The relative importance of Staphylococcus saprophyticus as a urinary tract pathogen: distribution of bacteria among urinary samples analysed during 1 year at a major Swedish laboratory
Eriksson A; Giske CG; Ternhag A
Article: PLOS ONE. 2013;8(12):e82069
Four Genotyping Schemes for Phylogenetic Analysis of Pseudomonas aeruginosa: Comparison of Their Congruence with Multi-Locus Sequence Typing
Maatallah M; Bakhrouf A; Habeeb MA; Turlej-Rogacka A; Iversen A; Pourcel C; Sioud O; Giske CG
Journal article: ARCHIVES OF DISEASE IN CHILDHOOD. 2012;97(Suppl 2):a333
1162 Comparative Analysis of Staphylococcus Epidermidis Strains Isolated From Newborns
Hell E; Giske C; Danielsson KG; Marchini G
Journal article: ARCHIVES OF DISEASE IN CHILDHOOD. 2012;97(Suppl 2):a381
1338 High Proportion of Intestinal ESBL Colonization Among Infants at a Neonatal Intensive Care Unit in a Tertiary Hospital in Ecuador
Nordberg V; Quizphe A; Giske C; Iversen A; Galindo T; Ochoa E; Navér L
Article: APMIS. 2012;120(9):724-732
Evaluation of Rosco Neo-Sensitabs for phenotypic detection and subgrouping of ESBL-, AmpC- and carbapenemase-producing Enterobacteriaceae
Hansen F; Hammerum AM; Skov RL; Giske CG; Sundsfjord A; Samuelsen O
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2012;44(9):641-649
Prevalence of antibiotic-resistant bacteria in residents of nursing homes in a Swedish municipality: Healthcare staff knowledge of and adherence to principles of basic infection prevention
Andersson H; Lindholm C; Iversen A; Giske CG; Ortqvist A; Kalin M; Fossum B
Article: APMIS. 2012;120(8):612-621
First outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a Norwegian neonatal intensive care unit; associated with contaminated breast milk and resolved by strict cohorting
Rettedal S; Lohr IH; Natas O; Giske CG; Sundsfjord A; Oymar K
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2012;56(5):2735-2738
Diverse Sequence Types of Klebsiella pneumoniae Contribute to the Dissemination of bla_NDM-1 in India, Sweden, and the United Kingdom
Giske CG; Froding I; Hasan CM; Turlej-Rogacka A; Toleman M; Livermore D; Woodford N; Walsh TR
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2012;88(5):422-430
Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study
Kjellander C; Bjorkholm M; Cherif H; Kalin M; Giske CG
Article: MICROBIAL DRUG RESISTANCE. 2012;18(2):189-192
Efficacy of Pivmecillinam for Treatment of Lower Urinary Tract Infection Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae
Titelman E; Iversen A; Kalin M; Giske CG
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2012;18(3):E37-E45
The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach
Mouton JW; Brown DFJ; Apfalter P; Canton R; Giske CG; Ivanova M; MacGowan AP; Rodloff A; Soussy C-J; Steinbakk M; Kahlmeter G
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2012;18(3):268-281
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
Magiorakos A-P; Srinivasan A; Carey RB; Carmeli Y; Falagas ME; Giske CG; Harbarth S; Hindler JF; Kahlmeter G; Olsson-Liljequist B; Paterson DL; Rice LB; Stelling J; Struelens MJ; Vatopoulos A; Weber JT; Monnet DL
Journal article: DRUG RESISTANCE UPDATES. 2012;15(1-2):1
A rapidly growing number of therapeutics targeting tumor cell-intrinsic and -extrinsic processes is under development for individualized treatment of cancer patients.
Giske CG; Jonkers J
Article: PLOS ONE. 2012;7(12):e51981
Fecal Carriage of ESBL-Producing E. coli and K. pneumoniae in Children in Guinea-Bissau: A Hospital-Based Cross-Sectional Study
Isendahl J; Turlej-Rogacka A; Manjuba C; Rodrigues A; Giske CG; Naucler P
Article: MICROBIAL DRUG RESISTANCE. 2011;17(4):545-549
A Diversity of OXA-Carbapenemases and Class 1 Integrons Among Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates from Sweden Belonging to Different International Clonal Lineages
Karah N; Giske CG; Sundsfjord A; Samuelsen O
Article: APMIS. 2011;119(12):853-863
Antimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae
Titelman E; Iversen A; Kahlmeter G; Giske CG
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2011;17(12):1811-1816
Molecular characterization of VIM-producing Klebsiella pneumoniae from Scandinavia reveals genetic relatedness with international clonal complexes encoding transferable multidrug resistance
Samuelsen O; Toleman MA; Hasseltvedt V; Fuursted K; Leegaard TM; Walsh TR; Sundsfjord A; Giske CG
Article: CURRENT INFECTIOUS DISEASE REPORTS. 2011;13(5):416-425
When and how to cover for resistant gram-negative bacilli in severe sepsis and septic shock.
Hanberger H; Giske CG; Giamarellou H
Article: DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2011;70(1):137-141
In vitro activity of CXA-101 plus tazobactam (CXA-201) against CTX-M-14-and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae
Titelman E; Karlsson IM; Ge Y; Giske CG
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2011;17(5):668-674
Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase-producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems
Vading M; Samuelsen O; Haldorsen B; Sundsfjord AS; Giske CG
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2011;15(4):502-509
Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis
Schon T; Jureen P; Chryssanthou E; Giske CG; Sturegard E; Kahlmeter G; Hoffner S; Angeby KA
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2011;17(4):552-556
A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin
Giske CG; Gezelius L; Samuelsen O; Warner M; Sundsfjord A; Woodford N
Article: PLOS ONE. 2011;6(10):e25617
Population Structure of Pseudomonas aeruginosa from Five Mediterranean Countries: Evidence for Frequent Recombination and Epidemic Occurrence of CC235
Maatallah M; Cheriaa J; Backhrouf A; Iversen A; Grundmann H; Thuy D; Lanotte P; Mastouri M; Elghmati MS; Rojo F; Mejdi S; Giske CG
Article: LAKARTIDNINGEN. 2010;107(48):3040-3043
[More severe bacterial infections could be prevented with vaccine. Rotavirus, influenza and varicella cause thousands of hospital admissions].
Bennet R; Bogdanovic G; Giske CG; Eriksson M
Journal article: BLOOD. 2010;116(21):4868
Bacteremia In Hospitalized Patients with Malignant Blood Disorders: a Retrospective Comparative Study of Causative Agents and Antimicrobial Susceptibility Profiles
Kjellander CK; Cherif H; Björkholm M; Kalin M; Giske CG
Article: EUROSURVEILLANCE. 2010;15(46):22-34
Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts
Grundmann H; Livermore DM; Giske CG; Canton R; Rossolini GM; Campos J; Vatopoulos A; Gniadkowski M; Toth A; Pfeifer Y; Jarlier V; Carmeli Y
Article: JOURNAL OF MICROBIOLOGICAL METHODS. 2010;83(2):224-230
The DiversiLab system versus pulsed-field gel electrophoresis: Characterisation of extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae
Brolund A; Haeggman S; Edquist PJ; Gezelius L; Olsson-Liljequist B; Wisell KT; Giske CG
Article: LAKARTIDNINGEN. 2010;107(40):2392-2395
[Penicillin V and how three dosages became two and than three again. History behind treatment of otitis, sinusitis and pharyngo-tonsillitis].
Giske CG; Eriksson M; Hermansson A; Kumlien J; Odenholt I; Cars O
Article: APMIS. 2010;118(9):713-716
Outbreak of CTX-M-15-producing Klebsiella pneumoniae of sequence type 199 in a Latvian teaching hospital
Dumpis U; Iversen A; Balode A; Saule M; Miklasevics E; Giske CG
Article: JOURNAL OF MICROBIOLOGICAL METHODS. 2010;82(3):229-233
Development of a real-time SYBRGreen PCR assay for rapid detection of acquired AmpC in Enterobacteriaceae
Brolund A; Wisell KT; Edquist PJ; Elfstrom L; Walder M; Giske CG
Article: THE LANCET INFECTIOUS DISEASES. 2010;10(9):597-602
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Kumarasamy KK; Toleman MA; Walsh TR; Bagaria J; Butt F; Balakrishnan R; Chaudhary U; Doumith M; Giske CG; Irfan S; Krishnan P; Kumar AV; Maharjan S; Mushtaq S; Noorie T; Paterson DL; Pearson A; Perry C; Pike R; Rao B; Ray U; Sarma JB; Sharma M; Sheridan E; Thirunarayan MA; Turton J; Upadhyay S; Warner M; Welfare W; Livermore DM; Woodford N
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2010;16(7):909-911
Transthoracic fine-needle aspiration in the aetiological diagnosis of community-acquired pneumonia
Hernes SS; Hagen E; Tofteland S; Finsen NT; Christensen A; Giske CG; Spindler C; Bakke PS; Bjorvatn B
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2010;65(5):946-952
Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data
Angeby KA; Jureen P; Giske CG; Chryssanthou E; Sturegard E; Nordvall M; Johansson AG; Werngren J; Kahlmeter G; Hoffner SE; Schon T
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2010;48(5):1853-1858
Wild-Type MIC Distributions for Aminoglycoside and Cyclic Polypeptide Antibiotics Used for Treatment of Mycobacterium tuberculosis Infections
Jureen P; Angeby K; Sturegard E; Chryssanthou E; Giske CG; Werngren J; Nordvall M; Johansson A; Kahlmeter G; Hoffner S; Schon T
Article: LAKARTIDNINGEN. 2010;107(11):742
[New guidelines for vancomycin in staphylococcal infections].
Giske CG; Odenholt I; Kahlmeter G
Journal article: DRUG RESISTANCE UPDATES. 2010;13(1-2):1
A message from the New Editor-in-Chief Drug Resistance Updates—The past and the future
Giske CG; Broxterman HJ
Article: LETTERS IN APPLIED MICROBIOLOGY. 2010;50(2):211-215
Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis
Hell E; Giske CG; Nelson A; Romling U; Marchini G
Article: CLINICAL INFECTIOUS DISEASES. 2010;50(2):202-209
Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods
Johansson N; Kalin M; Tiveljung-Lindell A; Giske CG; Hedlund J
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2010;54(1):346-352
Molecular Epidemiology of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa Isolates from Norway and Sweden Shows Import of International Clones and Local Clonal Expansion
Samuelsen O; Toleman MA; Sundsfjord A; Rydberg J; Leegaard TM; Walder M; Lia A; Ranheim TE; Rajendra Y; Hermansen NO; Walsh TR; Giske CG
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2009;53(12):5046-5054
Characterization of a New Metallo-β-Lactamase Gene, bla_NDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
Yong D; Toleman MA; Giske CG; Cho HS; Sundman K; Lee K; Walsh TR
Article: LAKARTIDNINGEN. 2009;106(47):3160-3161
["The wolf" is already here. Recent data in Stockholm shows increasing antibiotic resistance].
Kronvall G; Giske CG
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2009;64(4):786-793
Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis
Schon T; Jureen P; Giske CG; Chryssanthou E; Sturegard E; Werngren J; Kahlmeter G; Hoffner SE; Angeby KA
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2009;53(8):3365-3370
Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258
Kitchel B; Rasheed JK; Patel JB; Srinivasan A; Navon-Venezia S; Carmeli Y; Brolund A; Giske CG
Article: PEDIATRIC RESEARCH. 2009;66(2):174-178
Staphylococcus epidermidis Isolated From Newborn Infants Express Pilus-Like Structures and Are Inhibited by the Cathelicidin-Derived Antimicrobial Peptide LL37
Nelson A; Hultenby K; Hell E; Riedel HM; Brismar H; Flock J-I; Lundahl J; Giske CG; Marchini G
Article: MICROBIAL DRUG RESISTANCE. 2009;15(2):91-95
Interplay of Efflux, Impermeability, and AmpC Activity Contributes to Cefuroxime Resistance in Clinical, Non-ESBL-Producing Isolates of Escherichia coli
Kallman O; Giske CG; Samuelsen O; Wretlind B; Kalin M; Olsson-Liljequist B
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2009;63(4):654-658
Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden
Samuelsen O; Naseer U; Tofteland S; Skutlaberg DH; Onken A; Hjetland R; Sundsfjord A; Giske CG
Journal article: LAKARTIDNINGEN. 2009;106(5):291-292
[Time to abandon "the house wine". Stop for uncritical empiric use of cefuroxime].
Hanberger H; Odenholt I; Giske CG; Kahlmeter G
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2009;63(1):1-4
Redefining extended-spectrum β-lactamases: balancing science and clinical need
Giske CG; Sundsfjord AS; Kahlmeter G; Woodford N; Nordmann P; Paterson DL; Canton R; Walsh TR
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2008;62(5):986-990
Cefuroxime non-susceptibility in multidrug-resistant Klebsiella pneumoniae overexpressing ramA and acrA and expressing ompK35 at reduced levels
Kaellman O; Motakefi A; Wretlind B; Kalin M; Olsson-Liljequist B; Giske CG
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2008;46(5):1878-1880
Identification of the first VIM metallo-β-lactamase-producing multiresistant Aeromonas hydrophila strain
Libisch B; Giske CG; Kovacs B; Toth TG; Fuezi M
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2008;61(4):827-830
Evaluation of phenotypic tests for the detection of metallo-β-lactamase-producing Pseudomonas aeruginosa in a low prevalence country
Samuelsen O; Buaro L; Giske CG; Simonsen GS; Aasnaes B; Sundsfjord A
Article: MICROBIAL DRUG RESISTANCE. 2008;14(1):23-30
Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseudomonas aeruginosa
Giske CG; Buaro L; Sundsfjord A; Wretlind B
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2008;40(6-7):487-494
Antibiotic susceptibility patterns and clones of Pseudomonas aeruginosa in Swedish ICUs
Erlandsson M; Gill H; Nordlinder D; Giske CG; Jonas D; Nilsson LE; Walther S; Hanberger H
Article: LAKARTIDNINGEN. 2007;104(24-25):1906-1910
[Invasive pneumococcal infection can cause meningitis in children. Uncertainty about the mass protective effect of the vaccine from USA].
Eriksson M; Bennet R; Fuhrmann D; Giske CG; Rylander M
Journal article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2007;29:s90-s91
O432 Polyclonal distribution of extended-spectrumβlactamase-producing Escherichia coli and Klebsiella pneumoniae in Stockholm
Titelman E; Iversen A; Lagergren Å; Kühn I; Kahlmeter G; Giske C
Journal article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2007;29:s225
P871 Phenotypic detection of AmpC in E. coli: comparison of cloxacillin, boronic acid and EDTA disk synergy assays
Giske C; Haldorsen B; Lundblad E; Aasnæs B; Simonsen G; Sundsfjord A
Journal article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2007;29:s223-s224
P867 Carbapenem resistance mechanisms in Norwegian clinical isolates of Pseudomonas aeruginosa
Samuelsen Ø; Buarø L; Aasnæs B; Giske CG; Haldorsen B; Simonsen GS; Leegaard TM; Sundsfjord A
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2006;44(12):4309-4315
Establishing clonal relationships between VIM-1-like metallo-β-lactamase-producing Pseudomonas aeruginosa strains from four European countries by multilocus sequence typing
Giske CG; Libisch B; Colinon C; Scoulica E; Pagani L; Fuzi M; Kronvall G; Rossolini GM
Article: LAKARTIDNINGEN. 2006;103(35):2478-2481
[Nosocomial infections with multiresistant bacteria--not only staphylococci].
Petersson J; Giske CG; Aufwerber E; Jörbeck H
Article: DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2006;55(3):169-178
Quantitative detection of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in lower respiratory tract samples by real-time PCR
Kais M; Spindler C; Kalin M; Ortqvist A; Giske CG
Article: LAKARTIDNINGEN. 2006;103(14):1121-1122
[Quinolones should not be administered in monotherapy for Pseudomonas aeruginosa infection].
Giske CG; Wretlind B
Article: APMIS. 2005;113(3):187-196
Carbapenem resistance mechanisms in Pseudomonas aeruginosa:: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates
El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
Visa fler

Alla övriga publikationer

Review: CLINICAL INFECTIOUS DISEASES. 2024;79(2):516-523
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute
Narayanan N; Mathers AJ; Wenzler E; Moore NM; Giske CG; Mendes RE; Edelstein PH
Preprint: BIORXIV. 2024
GPT-4 based AI agents – the new expert system for detection of antimicrobial resistance mechanisms?
Giske CG; Bressan M; Fiechter F; Hinic V; Mancini S; Nolte O; Egli A
Letter: CLINICAL INFECTIOUS DISEASES. 2024;:ciae246
Amoxicillin-Clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute
Narayanan N; Mathers AJ; Wenzler E; Moore NM; Giske CG; Mendes RE; Edelstein PH
Review: INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY. 2023;12(3):211-225
The In vitro activity of carbapenems alone and in combination with β-lactamase inhibitors against difficult-to-treat mycobacteria; Mycobacterium tuberculosis, Mycobacterium abscessus, and Mycobacterium avium complex: A systematic review
Andersson V; Froberg G; Dahl V; Chryssanthou E; Giske C; Schon T; Forsman L
Editorial comment: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2022;28(9):1179-1181
The clinical impact of errors in semiautomated antimicrobial susceptibility testing of multidrug-resistant Enterobacterales causing bloodstream infections
Sundsfjord A; Giske C
Preprint: BIORXIV. 2022
Network-based multi-omics integration reveals metabolic at-risk profile within treated HIV-infection
Mikaeloff F; Gelpi M; Benfeitas R; Knudsen AD; Vestad B; Høgh J; Hov JR; Benfield T; Murray D; Giske CG; Mardinoglu A; Trøseid M; Nielsen SD; Neogi U
Editorial comment: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2022;28(6):764-767
Expected phenotypes and expert rules are important complements to antimicrobial susceptibility testing Comment
Gatermann S; Das S; Dubreuil L; Giske CG; Kahlmeter G; Lina G; Lindemann C; MacGowan A; Meletiadis J; Rossolini GM; Turnidge J; Canton R
Letter: PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2022;41(4):e182-e185
Searching High and Low: Call for a Joint European Society for Paediatric Infectious Diseases-European Committee on Antimicrobial Susceptibility Testing Survey on Dosage of Antibacterial Agents in Children-Part One
Aguilera-Alonso D; Canton R; Giske CG; Kahlmeter G; Kohns Vasconcelos M; Papan C; Turnidge J
Letter: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2022;28(4):625-627
Searching high and low: call for a joint ESPID-EUCAST survey on dosage of antibacterial agents in children-part one
Aguilera-Alonso D; Canton R; Giske CG; Kahlmeter G; Vasconcelos MK; Papan C; Turnidge J
Review: JOURNAL OF CLINICAL MICROBIOLOGY. 2022;60(3):e0027621-e00221
Update from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)
Giske CG; Turnidge J; Canton R; Kahlmeter G
Review: CURRENT OPINION IN INFECTIOUS DISEASES. 2021;34(6):599-610
New evidence for managing Gram-negative bloodstream infections
Nutman A; Tellapragada C; Giske CG; Yahav D
Corrigendum: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2021;40(12):2487-2488
The Unyvero Hospital-Acquired pneumonia panel for diagnosis of secondary bacterial pneumonia in COVID-19 patients (vol 4, pg 1, 2021)
Tellapragada C; Giske CG
Letter: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021;76(7):1949-1950
Comment on: Efficacy of temocillin against MDR Enterobacterales: a retrospective cohort study
Giske CG; Kahlmeter G; MacGowan A; Turnidge J
Letter: THE LANCET INFECTIOUS DISEASES. 2021;21(5):e117
Beyond COVID-19-a paradigm shift in infection management?
Vehreschild MJGT; Tacconelli E; Giske CG; Peschel A
Review: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2021;57(5):106344
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli
Scudeller L; Righi E; Chiamenti M; Bragantini D; Menchinelli G; Cattaneo P; Giske CG; Lodise T; Sanguinetti M; Piddock LJV; Franceschi F; Ellis S; Carrara E; Savoldi A; Tacconelli E
Corrigendum: CLINICAL MICROBIOLOGY REVIEWS. 2021;34(2):e00021
New β-Lactam-β-Lactamase Inhibitor Combinations (vol 34, e00115-20, 2021)
Yahav D; Giske CG; Gramatniece A; Abodakpi H; Tam VH; Leibovici L
Review: CLINICAL MICROBIOLOGY REVIEWS. 2020;34(1):e00115-e00120
New β-Lactam-β-Lactamase Inhibitor Combinations.
Yahav D; Giske CG; Grāmatniece A; Abodakpi H; Tam VH; Leibovici L
Letter: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2020;26(12):1692-1693
Re: In the name of common sense: EUCAST breakpoints and potential pitfalls. National dissemination of EUCAST guidelines is a shared responsibility.
Kahlmeter G; Cantón R; Giske CG; Turnidge J; EUCAST Steering Committee
Preprint: MEDRXIV. 2020
The Unyvero Hospital-Acquired pneumonia panel for diagnosis of secondary bacterial pneumonia in COVID-19 patients
Tellapragada C; Giske CG
Editorial comment: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2020;26(11):1453-1455
What is the role of the EUCAST reference method for MIC testing of the Mycobacterium tuberculosis complex?
Schon T; Koser CU; Werngren J; Viveiros M; Georghiou S; Kahlmeter G; Giske C; Maurer F; Lina G; Turnidge J; van Ingen J; Jankovic M; Goletti D; Maria Cirillo D; Santin M; Cambau E
Other: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2020;26(1):125-126
Obituary: Johan Willem Mouton
Kluytmans J; Voss A; Kahlmeter G; Giske C; MacGowan A; Brown D; Gatermann S; Lina G; Lindemann C; Turnidge J; Canton R; Petinaki E; Vaz CP; Rodriguez Bano J
Letter: JOURNAL OF CLINICAL MICROBIOLOGY. 2019;58(1):e01519
Reply from Kahlmeter and Giske to Brecher, 'EUCAST and CLSI Point-Counterpoint on Susceptibility Breakpoints: Do Two "I Agree"s Miss the Point?'
Kahlmeter G; Giske CG
Review: JOURNAL OF CLINICAL MICROBIOLOGY. 2019;57(9):e01129-e01119
Point-Counterpoint: Differences between the European Committee on Antimicrobial Susceptibility Testing and Clinical and Laboratory Standards Institute Recommendations for Reporting Antimicrobial Susceptibility Results
Kahlmeter G; Giske CG; Kirn TJ; Sharp SE
Conference publication: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2019;75:S12
Interindividual variability in plasma levels of beta-lactam antibiotics in critically ill patients with or without continuous renal replacement therapy
Eliasson E; Giske C; Petersson J
Review: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2019;25(1):13-19
ESCMID generic competencies in antimicrobial prescribing and stewardship: towards a European consensus
Dyar OJ; Beovic B; Pulcini C; Tacconelli E; Hulscher M; Cookson B
Letter: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2018;24(12):1345
A plea from EUCAST for standardization of disc susceptibility testing antimicrobial codes
Turnidge J; Lina G; Giske C
Other: LAKARTIDNINGEN. 2018;115:FCX7
[Psittacosis - a forgotten diagnosis in Sweden?].
Marking U; Hammas B; Grabbe M; Giske C
Letter: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018;73(9):2585-2586
MIC-based dose adjustment: facts and fables-authors' response
Mouton JW; Muller AE; Canton R; Giske CG; Kahlmeter G; Turnidge J
Editorial comment: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2018;24(2):93-94
Colistin antimicrobial susceptibility testing-can the slow and challenging be replaced by the rapid and convenient?
Giske CG; Kahlmeter G
Review: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2017;23(1):2-22
The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee
Ellington MJ; Ekelund O; Aarestrup FM; Canton R; Doumith M; Giske C; Grundman H; Hasman H; Holden MTG; Hopkins KL; Iredell J; Kahlmeter G; Koser CU; MacGowan A; Mevius D; Mulvey M; Naas T; Peto T; Rolain J-M; Samuelsen O; Woodford N
Review: FEMS MICROBIOLOGY REVIEWS. 2016;40(4):437-463
Escherichia coli: an old friend with new tidings
Vila J; Saez-Lopez E; Johnson JR; Romling U; Dobrindt U; Canton R; Giske CG; Naas T; Carattoli A; Martinez-Medina M; Bosch J; Retamar P; Rodriguez-Bano J; Baquero F; Soto SM
Review: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2015;21(10):899-905
Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin
Giske CG
Review: DRUG RESISTANCE UPDATES. 2015;20:29-38
Carbapenemase-producing Enterobacteriaceae in Sweden 2007-2013: Experiences from seven years of systematic surveillance and mandatory reporting
Lofmark S; Sjostrom K; Makitalo B; Edquist P; Wisell KT; Giske CG
Review: JOURNAL OF INTERNAL MEDICINE. 2015;277(5):501-512
Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control
Tangden T; Giske CG
Review: LAKARTIDNINGEN. 2015;112:CW3P
[Beta lactam antibiotics and the question of dose regimen for severe infection. Prolonged infusion theoretically appealing--yet no evidence of clinical benefit].
Leander G; Eliasson E; Hanberger H; Giske C
Review: UPSALA JOURNAL OF MEDICAL SCIENCES. 2014;119(2):154-161
Antibiotic consumption and antibiotic stewardship in Swedish hospitals
Hanberger H; Skoog G; Ternhag A; Giske CG
Conference publication: INTENSIVE CARE MEDICINE. 2014;40:S240-S241
MEROPENEM AND PIPERACILLIN CONCENTRATIONS IN ICU PATIENTS TREATED WITH CONTINUOUS RENAL REPLACEMENT THERAPY
Petersson J; Giske CG; Eliasson E
Conference publication: HAEMATOLOGICA. 2014;99:63
BLOOD STREAM INFECTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA: STABLE DISTRIBUTION BUT WITH INCREASED MORTALITY RATE?
Kjellander C; Bjorkholm M; Landgren O; Kallman O; Weibull CE; Love TJ; Giske CC; Kristinsson SY
Letter: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2013;45(8):655-656
Rational use of aminoglycosides - author response
Hanberger H; Fredriksson M; Ternhag A; Giske CG
Review: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2013;45(3):161-175
Rational use of aminoglycosides-Review and recommendations by the Swedish Reference Group for Antibiotics (SRGA)
Hanberger H; Edlund C; Furebring M; Giske CG; Melhus A; Nilsson LE; Petersson J; Sjolin J; Ternhag A; Werner M; Eliasson E
Review: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2013;19(2):141-160
EUCAST expert rules in antimicrobial susceptibility testing
Leclercq R; Canton R; Brown DFJ; Giske CG; Heisig P; MacGowan AP; Mouton JW; Nordmann P; Rodloff AC; Rossolini GM; Soussy C-J; Steinbakk M; Winstanley TG; Kahlmeter G
Conference publication: INTENSIVE CARE MEDICINE. 2013;39:S220
STANDARD DOSING REGIMENS OF PIPERACILLIN AND MEROPENEM FAIL TO ACHIEVE ADEQUATE SERUM CONCENTRATIONS IN ICU PATIENTS
Petersson J; Giske CG; Eliasson E
Conference publication: EUROPEAN RESPIRATORY JOURNAL. 2013;42
Relevance of respiratory infections in preschool wheeze - A hospital based study
Hammar KS; Hedlin G; Konradsen JR; Nordlund RB; Kull RI; Giske CG; Pedroletti C; Soderhall C; Melen E
Review: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2012;18(5):432-438
Identification and screening of carbapenemase-producing Enterobacteriaceae
Nordmann P; Gniadkowski M; Giske CG; Poirel L; Woodford N; Miriagou V
Review: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2012;18(5):413-431
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
Canton R; Akova M; Carmeli Y; Giske CG; Glupczynski Y; Gniadkowski M; Livermore DM; Miriagou V; Naas T; Rossolini GM; Samuelsen O; Seifert H; Woodford N; Nordmann P
Corrigendum: JOURNAL OF MICROBIOLOGICAL METHODS. 2012;88(1):188
Development of a real-time SYBRGreen PCR assay for rapid detection of acquired AmpC in Enterobacteriaceae (vol 82, pg 229, 2010)
Brolund A; Wisell KT; Edquist PJ; Elfstrom L; Walder M; Giske CG
Meeting abstract: PEDIATRIC RESEARCH. 2011;70:457
LONG-TERM FOLLOW-UP AFTER NEONATAL COLONIZATION WITH EXTENDED SPECTRUM BETA-LACTAMASE GRAM-NEGATIVE BACTERIA
Kock K; Jonsson B; Aspevall O; Iversen A; Giske CG; Nordberg V; Norman M; Naver L
Review: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2011;38(4):281-290
Setting interpretive breakpoints for antimicrobial susceptibility testing using disk diffusion
Kronvall G; Giske CG; Kahlmeter G
Letter: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2011;55(9):4492-4493
Wild-Type MIC Distributions Must Be Considered To Set Clinically Meaningful Susceptibility Testing Breakpoints for All Bacterial Pathogens, Including Mycobacterium tuberculosis
Angeby K; Giske CG; Jureen P; Schon T
Review: DRUG RESISTANCE UPDATES. 2011;14(4-5):236-250
Epidemiology and characteristics of antimicrobial resistance in China
Xiao Y-H; Giske CG; Wei Z-Q; Shen P; Heddini A; Li L-J
Meeting abstract: PEDIATRIC RESEARCH. 2010;68:693
LONG-TERM FOLLOW-UP AFTER NEONATAL COLONIZATION WITH EXTENDED SPECTRUM BETA-LACTAMASE GRAM-NEGATIVE BACTERIA
Kokk K; Jonsson B; Aspevall O; Iversen A; Giske CG; Norman M; Naver L
Review: DRUG RESISTANCE UPDATES. 2010;13(4-5):93-98
Supranational surveillance of antimicrobial resistance: The legacy of the last decade and proposals for the future
Giske CG; Cornaglia G
Meeting abstract: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2010;14:E179
Detecting Carbapenemase Producers in the Clinic
Giske C
Published conference paper: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2010;16(2):112-122
Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues
Miriagou V; Cornaglia G; Edelstein M; Galani I; Giske CG; Gniadkowski M; Malamou-Lada E; Martinez-Martinez L; Navarro F; Nordmann P; Peixe L; Pournaras S; Rossolini GM; Tsakris A; Vatopoulos A; Canton R
Review: LAKARTIDNINGEN. 2009;106(34):2052-2056
[Quantitative lower respiratory tract cultures and how to interpret them. Infection must be discriminated from colonization].
Petersson J; Kalin M; Giske CG
Letter: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2009;64(2):430-431
Activity of cephalosporin CXA-101 (FR264205) and comparators against extended-spectrum-β-lactamase-producing Pseudomonas aeruginosa
Giske CG; Ge J; Nordmann P
Letter: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2009;64(1):213-215
Redefining extended-spectrum β-lactamases: balancing science and clinical need-authors' response
Giske CG; Sundsfjord AS; Kahlmeter G; Woodford N; Nordmann P; Paterson DL; Canton R; Walsh TR
Letter: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2009;53(1):331-332
The First Metallo-β-Lactamase Identified in Norway Is Associated with a TniC-Like Transposon in a Pseudomonas aeruginosa Isolate of Sequence Type 233 Imported from Ghana
Samuelsen O; Buaro L; Toleman MA; Giske CG; Hermansen NO; Walsh TR; Sundsfjord A
Review: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2008;62(1):35-40
Trimethoprim and enterococci in urinary tract infections: new perspectives on an old issue
Wisell KT; Kahlmeter G; Giske CG
Review: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2008;52(3):813-821
Clinical and economic impact of common multidrug-resistant gram-negative bacilli
Giske CG; Monnet DL; Cars O; Carmeli Y
Published conference paper: DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2008;60(3):255-261
Quantitative detection of Streptococcus pneumoniae from sputum samples with real-time quantitative polymerase chain reaction for etiologic diagnosis of community-acquired pneumonia
Johansson N; Kalin M; Giske CG; Hedlund J
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2008;68(2):246-247
Staphylococcus epidermidis isolated from newborn infants express pilus structures
Nelson A; Hultenby K; Riedel H; Giske C; Motakefi A; Marchini G
Thesis / dissertation: 2007
Carbapenem resistance in Pseudomonas aeruginosa
Giske, Christian
Published conference paper: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2005;11(8):662-669
Meropenem susceptibility breakpoint for Pseudomonas aeruginosa strains hyperproducing mexB mRNA
Giske CG; Borén C; Wretlind B; Kronvall G
Letter: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2003;47(9):3034-3035
VIM-4 in a carbapenem-resistant strain of Pseudomonas aeruginosa isolated in Sweden
Giske CG; Rylander M; Kronvall G
Visa fler

Forskningsbidrag

Improving surveillance of antibiotic-resistant Pseudomonas aeruginosa in Europe
Swedish Research Council
1 January 2023 - 31 December 2023
IDAR-Neo - Identification and characterization of fecal carriage of antimicrobial resistant bacteria in neonates in low-resource settings
Swedish Research Council
1 January 2023 - 31 December 2025
Pivmecillinam in the treatment of urinary tract infections caused by ESBL-producing bacteria - a randomized study
Swedish Research Council
1 January 2022 - 31 December 2023
Bridging the knowledge gap in adaptive drug resistance and fitness properties of Gram-negative bacteria
Swedish Research Council
1 December 2020 - 31 December 2022
Identification of bacterial infections and antibiotic resistance in low income countries by rapid optical DNA mapping
Swedish Research Council
1 January 2020 - 31 December 2022
Microbial and host responses in the respiratory tract of covid-19 patients as a basis for optimal treatment
Swedish Heart-Lung Foundation
1 January 2020 - 31 December 2020
Individualiserad behandling av multiresistent tuberkulos genom användning av nya diagnostiska och farmakologiska strategier samt nya läkemedelsgrupper
Swedish Heart-Lung Foundation
1 January 2020 - 31 December 2022
Carbapenem resistance in Bacteroides fragilis
Southern and Eastern Norway Regional Health Authority
1 January 2019
Plasmid Identification and Detection in South-East Asia - Enterobacteriaceae resistant to last resort Carbapenems and Colistin
Swedish Research Council
1 April 2018 - 31 December 2020
Impact of Prescription Quality, Infection Control and Antimicrobial Stewardship on Gut Microbiota Domination by Healthcare-Associated Pathogens (PILGRIM)
Swedish Research Council
1 December 2017 - 31 December 2019
Selection and development of a therapeutic antibody against drug-resistant Klebsiella pneumoniae
VINNOVA
1 November 2017 - 1 November 2020
Portable diagnostics for disease and drug resistance with focus on malaria and bacterial infections
Swedish Research Council
1 January 2017 - 31 December 2019
Exploring the role of prophages and the CRISPR/Cas system in successful clones of extensively drug resistant Klebsiella pneumoniae
Swedish Research Council
1 January 2017 - 31 December 2019
Multi-resistant Klebsiella pneumoniae in newborns.
Western Norway Regional Health Authority
1 January 2011 - 31 December 2014

Anställningar

Professor/Överläkare, Laboratoriemedicin, Karolinska Institutet, 2018-

Examina och utbildning

Docent, Klinisk mikrobiologi, Karolinska Institutet, 2010
MEDICINE DOKTORSEXAMEN, Institutionen för mikrobiologi, tumör- och cellbiologi, Karolinska Institutet, 2007

Om mig

Utvalda publikationer

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI